Stuttgart - Delayed Quote EUR
Xspray Pharma AB (publ) (6XP.SG)
3.2950
-0.1050
(-3.09%)
As of 8:05:35 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
287,041
287,041
181,734
131,382
96,951
Operating Income
-287,041
-287,041
-181,734
-131,382
-96,951
Net Non Operating Interest Income Expense
1,368
1,368
2,050
1,403
1,255
Pretax Income
-285,674
-285,674
-179,684
-131,670
-96,698
Tax Provision
-151
-151
-17
--
--
Net Income Common Stockholders
-285,523
-285,523
-179,667
-131,670
-96,698
Diluted NI Available to Com Stockholders
-285,523
-285,523
-179,667
-131,670
-96,698
Basic EPS
-7.80
-8.62
-6.76
-6.18
-4.93
Diluted EPS
-7.80
-8.62
-6.76
-6.18
-4.93
Basic Average Shares
33,044.7210
33,137.3060
26,593.9100
21,323.3640
19,646.1210
Diluted Average Shares
33,044.7210
33,137.3060
26,593.9100
21,323.3640
19,646.1210
Total Operating Income as Reported
-287,041
-287,041
-181,734
-133,073
-97,953
Total Expenses
287,041
287,041
181,734
131,382
96,951
Net Income from Continuing & Discontinued Operation
-285,523
-285,523
-179,667
-131,670
-96,698
Normalized Income
-285,523
-285,523
-179,667
-131,670
-96,698
Interest Income
3,297
3,297
2,725
1,415
1,259
Interest Expense
1,929
1,929
675
12
4
Net Interest Income
1,368
1,368
2,050
1,403
1,255
EBIT
-283,745
-283,745
-179,009
-131,658
-96,694
EBITDA
-275,198
-275,198
-169,815
-122,125
-87,824
Reconciled Depreciation
8,547
8,547
9,194
9,533
8,870
Net Income from Continuing Operation Net Minority Interest
-285,523
-285,523
-179,667
-131,670
-96,698
Normalized EBITDA
-275,198
-275,198
-169,815
-122,125
-87,824
Tax Rate for Calcs
0
0
0
--
--
12/31/2021 - 5/11/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade